Latest / Pharmacy Podcast Network / Establishing a “Win-Win” Relationship with Government Agencies and PBMs | NASP Specialty Pharmacy Podcast
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:09Speaker 1: to the pharmacy profession. Welcome to the Pharmacy podcast Network.
- 0:27Speaker 2: You are listening to the NASP podcast. This Specialty Pharmacy
- 0:32Speaker 2: podcast is a collaboration with the National Association of Specialty
- 0:36Speaker 2: Pharmacy and the Pharmacy Podcast Network. The mission of the
- 0:39Speaker 2: National Association of Specialty Pharmacy is to improve specialty pharmacy
- 0:43Speaker 2: practice by promoting continuing professional education and certification of specialty
- 0:49Speaker 2: pharmacists while advocating for public policies that ensure patient access
- 0:53Speaker 2: to specialty medications. As the healthcare industry's leading podcasts dedicated
- 0:58Speaker 2: to the pharmacy profession, Pharmacy Podcast Network is proud to
- 1:02Speaker 2: bring our listeners the NASP Podcast in collaboration with a
- 1:06Speaker 2: National Association of Specialty Pharmacy.
- 1:08Speaker 3: Hello, my name is Sheila Arcatt and I am the
- 1:10Speaker 3: President and CEO of the National Association of Specialty Pharmacy.
- 1:14Speaker 3: I am delighted to welcome my very special guests, Jeff
- 1:17Speaker 3: Baird and Brad Howard to this episode of the NASP podcast.
- 1:21Speaker 4: Jeffrey S.
- 1:22Speaker 3: Baird is Chairman of the Healthcare Group at Brown and Fortunado,
- 1:26Speaker 3: a law firm with a national healthcare practice based in Texas.
- 1:29Speaker 3: He represents pharmacies, infusion companies, HMME companies, manufacturers, and other
- 1:35Speaker 3: healthcare providers throughout the United States. Mister Baird is Board
- 1:39Speaker 3: certified in health law by the Texas Board of Legal
- 1:42Speaker 3: Specialization and can be reached at area code eight zero
- 1:46Speaker 3: six three four five six three two zero or j
- 1:53Speaker 3: BA Ird at bf DASH Law dot com.
- 1:59Speaker 4: Bradley W.
- 2:00Speaker 3: Howard is a litigator with an emphasis in health and
- 2:02Speaker 3: employment law, and he is a shareholder and director at
- 2:06Speaker 3: Brown and Fortunado. Brad received his BA from Texas Tech
- 2:10Speaker 3: University in nineteen eighty eight, graduating summa cum laude. After college,
- 2:15Speaker 3: Brad continued his education at the University of Texas School
- 2:18Speaker 3: of Law. He received his jd in nineteen ninety one
- 2:21Speaker 3: and is admitted to practice law in Texas, New Mexico, Iowa, Colorado,
- 2:26Speaker 3: and Oklahoma. Brad handles governmental investigations, business disputes, and litigation
- 2:31Speaker 3: involving healthcare providers, including DME companies, home health agencies, pharmacies,
- 2:37Speaker 3: and hospitals. Brad is Board certified in labor and Employment
- 2:40Speaker 3: law by the Texas Board of Legal Specialization. He is
- 2:44Speaker 3: active in many trade associations, including the American Health Lawyers Association,
- 2:49Speaker 3: then New Mexico Health Law Section Board of Directors, the
- 2:52Speaker 3: Society for Human Resource Management, the Amarillo Area Bar Association,
- 2:58Speaker 3: and the Panhandle Human Resources Association. Brad can be reached
- 3:03Speaker 3: at area code eight zero six three four five six
- 3:07Speaker 3: three one zero or via email at B Howard at
- 3:14Speaker 3: bf dash Law dot com. Jeff and Brad, thanks so
- 3:18Speaker 3: much for joining me today.
- 3:20Speaker 4: Hey, Sheila, We're glad to be here. It's you know,
- 3:22Speaker 4: Brown FORTUNEODL has had long time relations a long standing
- 3:26Speaker 4: relationship with NASP. It is a great organization, it's the best,
- 3:31Speaker 4: the best. You are an excellent executive director, and you
- 3:36Speaker 4: know the the services that NASB provides to the specialty
- 3:43Speaker 4: pharmacy profession is just unmatched. And so anytime that we
- 3:48Speaker 4: here at Brown FORTUNEADL can help you and help your
- 3:52Speaker 4: team with education, we'll step up and do it. Brad,
- 3:55Speaker 4: your thoughts.
- 3:57Speaker 5: Absolutely, it's a pleasure to be here, Sheila, thanks a
- 3:59Speaker 5: lot for I guess we love doing these podcasts because
- 4:02Speaker 5: you get a chance to convey a lot of information
- 4:03Speaker 5: to your members, but in a very casual, kind of
- 4:06Speaker 5: relaxed way, which we love to do like that.
- 4:09Speaker 6: So thanks for having us today.
- 4:10Speaker 3: Oh my gosh, thank you so much for all your support.
- 4:12Speaker 3: Like Jeff, like you said, you and I have been
- 4:15Speaker 3: connected and working together for quite some time. And I
- 4:18Speaker 3: mean you've just been instrumental in what the Legal Committee
- 4:21Speaker 3: has done and delivered for members or Specialty Pharmacy Law Conference,
- 4:24Speaker 3: all of it. So I can't thank both you and
- 4:26Speaker 3: Brad enough for everything that you've done for us.
- 4:29Speaker 4: Well, thank you. We're glad to do it.
- 4:31Speaker 3: All right, So let's talk corporate compliance. So what is
- 4:34Speaker 3: a corporate compliance program and how does it help with
- 4:37Speaker 3: pharmacy to avoid and fix mistakes.
- 4:40Speaker 4: Yeah, a compliance program is something that's fairly unique to healthcare,
- 4:46Speaker 4: and that's because healthcare providers be at pharmacies, hospitals, position
- 4:51Speaker 4: groups have to comply with a whole bunch of federal
- 4:57Speaker 4: and state laws, particularly for a new use laws. And
- 5:00Speaker 4: that's because we as pharmacies, you know, we receive or
- 5:06Speaker 4: the payment sources we get are from taxpayer money and
- 5:09Speaker 4: from insurance companies and what have you, and so there's
- 5:13Speaker 4: there are laws in place to to protect tax payer
- 5:18Speaker 4: money and money coming in from insurance companies and so
- 5:23Speaker 4: a compliance program is is kind of the don't put
- 5:27Speaker 4: this way. A corporate any corporation has a set of
- 5:31Speaker 4: bylaws and it governs how the corporations run. Or a
- 5:35Speaker 4: limited liability company has what's called an operating agreement and
- 5:39Speaker 4: that governs how decisions are made for the limited liability
- 5:43Speaker 4: company or LLC. Well, compliance plan is a written document.
- 5:47Speaker 4: It's not particularly rocket science, but it's kind of a
- 5:49Speaker 4: detailed document that lays out what the laws are that
- 5:59Speaker 4: farm macies need to follow, how, you know, the pharmacy
- 6:04Speaker 4: is to comply with those laws, what steps it needs
- 6:07Speaker 4: to take. The compliance program, which is you know, is
- 6:12Speaker 4: a multi page document that needs to be amended on
- 6:16Speaker 4: a regular basis, modified and updated. You know, talks about
- 6:20Speaker 4: how to spot problems. And then, lastly and equally is
- 6:25Speaker 4: important is when problems arise, which they will. Every pharmacy,
- 6:29Speaker 4: every law firm, every company is going to have problems,
- 6:31Speaker 4: and when they arise, how to resolve the problems. Probably,
- 6:36Speaker 4: Sheila and Bradley, you know, one of the most important
- 6:39Speaker 4: components of a compliance program is the appointment of a
- 6:44Speaker 4: compliance officer. You know, for a big specialty pharmacy, you know,
- 6:48Speaker 4: this can be a full time gig. For a smaller pharmacy,
- 6:52Speaker 4: the compliance officer can wear a couple of different hats,
- 6:56Speaker 4: but the important and virtually all compliants well, the vast, vast,
- 7:01Speaker 4: vast majority of compliance officers are not are not attorneys.
- 7:04Speaker 4: They're just really smart, competent people who are focusing on
- 7:09Speaker 4: the laws and policies that a pharmacy must follow. So
- 7:13Speaker 4: it's to not get in trouble with government enforcement agencies
- 7:16Speaker 4: and the biggest I think the most important feature of
- 7:23Speaker 4: a competent of a good compliance officer is for he
- 7:28Speaker 4: or she to be the proverbial quote canary in the
- 7:32Speaker 4: mind shaft close quote. The compliance officer doesn't have to
- 7:35Speaker 4: be an expert on what the laws are because normally
- 7:39Speaker 4: he or she's not going to be an attorney, but
- 7:41Speaker 4: he or she needs to know enough to, you know,
- 7:46Speaker 4: to have the kind of a Pavlovian reaction when kind
- 7:52Speaker 4: of nervous twitch when the pharmacy is about to do
- 7:56Speaker 4: something that makes the compliance officer feel uncomfortable, well that's
- 8:01Speaker 4: when the compliance officer steps up and says, Okay, let's
- 8:03Speaker 4: do a time out and call our healthcare turn. Let's
- 8:06Speaker 4: make sure that you know what we're doing is not
- 8:09Speaker 4: going to get us into trouble. So that's what a
- 8:11Speaker 4: compliance program is. Brad your thoughts if I've gone off
- 8:15Speaker 4: the rails, bring me back on.
- 8:17Speaker 6: No, that's right, that's right on.
- 8:18Speaker 5: I find Sheila and Jeff that in a lot of
- 8:22Speaker 5: the investigations, the healthcare and pharmacy investigations I handle where
- 8:26Speaker 5: the government has reached out with a subpoena or maybe
- 8:29Speaker 5: a civil investigative demand, or as you show up and
- 8:34Speaker 5: they want to know about certain business practices of the pharmacy.
- 8:38Speaker 5: A lot of times those complaints were provided to the
- 8:41Speaker 5: government by an employee or former employee who did not
- 8:44Speaker 5: I'm not saying always been in a lot of cases,
- 8:47Speaker 5: did not feel comfortable to raise that concern directly to
- 8:50Speaker 5: the pharmacy to address it. And that's one of the
- 8:53Speaker 5: best aspects of a corporate compliance program is it encourages employees.
- 8:58Speaker 5: You have concerns about the way we're doing something, questions
- 9:01Speaker 5: about some of our practices, raise them with the compliance officer,
- 9:05Speaker 5: raise them with the company. Give us a chance to
- 9:08Speaker 5: talk to you about that and get you comfortable with
- 9:10Speaker 5: what we're doing.
- 9:11Speaker 6: Because in the cases where.
- 9:13Speaker 5: That isn't present, the only other recourse is for the
- 9:16Speaker 5: employee to go to the government and whistle blow, and
- 9:19Speaker 5: that happens far too often when it could be avoided.
- 9:23Speaker 3: All right, So a PBM sends a letter to a
- 9:26Speaker 3: specialty pharmacy that includes assertions that the pharmacies engaged in
- 9:30Speaker 3: activities that violate the contract between the PBM and the pharmacy.
- 9:34Speaker 3: So let's look at two scenarios. The first, the pharmacy
- 9:37Speaker 3: knows that the PBM's assertions are wrong. How should the
- 9:40Speaker 3: pharmacy respond? And then the second scenario, the pharmacy knows
- 9:44Speaker 3: that the PBM's assertions aren't correct. How should they respond?
- 9:48Speaker 5: Yeah, I'll take a lead on that one, if it's
- 9:50Speaker 5: all right, Jeff, you bed. So let's let's start with
- 9:53Speaker 5: the first scenario. And these are both These are both
- 9:56Speaker 5: very common scenarios, and I mean, these are all very
- 9:59Speaker 5: real world questions because a lot of our pharmacy clients
- 10:03Speaker 5: do receive letters from PBMs, and in many cases the
- 10:07Speaker 5: allegations are unfounded. So in that first scenario, let's say
- 10:11Speaker 5: the PBM is wrong, first thing I would do is
- 10:13Speaker 5: I would get your lawyer involved to at least review
- 10:16Speaker 5: a draft before you respond, because a lot of times
- 10:19Speaker 5: when someone's upset about an accusation that isn't true, you
- 10:23Speaker 5: react rather than respond. It might have a little bit
- 10:27Speaker 5: too much emotion and might involve a phone call to
- 10:29Speaker 5: the PBM or you know, somebody saying, hey, that's a
- 10:31Speaker 5: bunch of you know crap. I mean, we didn't do that,
- 10:34Speaker 5: We don't do those.
- 10:35Speaker 6: Well, it isn't going to go well if the pharmacy reacts.
- 10:38Speaker 5: So we always recommend gets your lawyer involved at the
- 10:41Speaker 5: beginning and have them work with you on this. But
- 10:43Speaker 5: to respond rather than react, usually in writing.
- 10:46Speaker 6: Is what we tell clients to do.
- 10:49Speaker 5: It's got to be a very professional response in the
- 10:52Speaker 5: sense that you want to take the emotion, the anger,
- 10:56Speaker 5: the you know, mistreatment, You want to take that part
- 10:58Speaker 5: out of it and keep it very professional. I like
- 11:01Speaker 5: pharmacies to respond to those with a lot of facts
- 11:04Speaker 5: and set the record straight, unequivocally, so you know, we
- 11:07Speaker 5: weren't were not engaged in that practice that you're talking about,
- 11:11Speaker 5: and then they explain the reasons why.
- 11:13Speaker 6: But don't don't stop there.
- 11:15Speaker 5: I think it's a good opportunity to take that bad
- 11:17Speaker 5: situation and turn it around to something more positive. So
- 11:21Speaker 5: you want to provide them information about your pharmacy, educated
- 11:25Speaker 5: about your your pharmacy's background, it's focused on patient care.
- 11:31Speaker 5: It's good practices, your commitment to compliance. If it's helpful,
- 11:36Speaker 5: maybe the history of the pharmacy. But tell the PBM
- 11:39Speaker 5: all about who you are, why the relationship with that
- 11:42Speaker 5: PBM is very valuable to its page, to its members,
- 11:45Speaker 5: to the patients that the pharmacy serves. And then you're
- 11:49Speaker 5: ending strong. You're you're rebutting the concerns, but not in
- 11:53Speaker 5: a real negative way. You're making it a positive thing
- 11:55Speaker 5: to get off their their lists.
- 11:58Speaker 4: There there, let me let me kind of jump in.
- 12:01Speaker 6: It's you.
- 12:01Speaker 4: We have to understand that at the end of the day,
- 12:05Speaker 4: the PBM is in a superior bargaining possession position. Lawyers
- 12:10Speaker 4: like to use the term that possession is nine tenths
- 12:12Speaker 4: of the law. Well, the PBM possesses our money, and
- 12:16Speaker 4: so whether it is right or wrong in some ways,
- 12:19Speaker 4: it doesn't matter. It possesses our money, and so we
- 12:23Speaker 4: have there's a problem that needs to be solved. We
- 12:25Speaker 4: don't need to win the battle or win the war.
- 12:27Speaker 4: We need to solve the problem so we can go
- 12:30Speaker 4: on and live another day and so, as Brad said,
- 12:33Speaker 4: we don't have as a pharmacy, we don't have the
- 12:36Speaker 4: luxury being righteously indignant. Rather, we are approach is to
- 12:41Speaker 4: solve the problem the other thing, Brad. In fact, I'll
- 12:44Speaker 4: let you you know more about this than I do.
- 12:47Speaker 4: When I know it's kind of self serving to say,
- 12:51Speaker 4: bring your healthcare lawyer in, but you need to and
- 12:57Speaker 4: the but the actual response back to the should that
- 13:01Speaker 4: come from the lawyer, Brad, Or should that come from
- 13:03Speaker 4: the pharmacy.
- 13:04Speaker 6: Yeah? No, usually from the pharmacy directly.
- 13:06Speaker 5: What I want to be involved in one of those
- 13:07Speaker 5: It might just be kind of quality control or final review,
- 13:11Speaker 5: final edits to the draft letter. I like the response
- 13:14Speaker 5: to come back from the pharmacy on its letter head
- 13:17Speaker 5: or through its email, because you want the file to reflect.
- 13:21Speaker 5: PBM raised a concern of pharmacy, and pharmacy responded, and
- 13:25Speaker 5: then my work for the or any lawyers work for
- 13:28Speaker 5: the pharmacy, and at least in my opinion, should usually
- 13:31Speaker 5: be behind the scenes.
- 13:33Speaker 4: Yeah, the PBM doesn't at this juncture unless things just
- 13:37Speaker 4: really go south. PBM doesn't want to hear from attorneys.
- 13:40Speaker 4: The PBM wants to hear from the pharmacy. And so
- 13:43Speaker 4: again the approach is when when let's solve the problem,
- 13:48Speaker 4: you PBM may not have all the information, so we're
- 13:53Speaker 4: now helping you out and we're going to work on
- 13:55Speaker 4: this together.
- 13:56Speaker 5: Yeah, and then the reason I like to put some
- 13:57Speaker 5: time into that, sheila some effort into it. Besides just
- 14:00Speaker 5: making the call saying these things aren't true or a
- 14:03Speaker 5: quick cursory letter. The reason I like to invest some
- 14:05Speaker 5: time and effort into the response is it may be
- 14:09Speaker 5: that the PBM got some bad information. So hey, take
- 14:14Speaker 5: the opportunity to pay yourself at a really good light to
- 14:18Speaker 5: the PBM while you're making the problem that Jeff referred to,
- 14:21Speaker 5: you know, go away. But you know, by contrast, but
- 14:24Speaker 5: the approach is a little bit different. Let's say that
- 14:28Speaker 5: you know, this never really happens to anybody that we
- 14:30Speaker 5: all know. But let's say that the PBM's correct. Let's
- 14:33Speaker 5: say they send a letter saying your pharmacies violated these
- 14:37Speaker 5: particular parts of our provider manual, of the contract, of
- 14:41Speaker 5: our relationship, of what you're allowed to do. You've run
- 14:44Speaker 5: a foul of all that, and they give you know,
- 14:47Speaker 5: one or more examples of how the pharmacy is not
- 14:49Speaker 5: in compliance.
- 14:51Speaker 4: And Cook Brad, this of course does happen.
- 14:54Speaker 6: It happens, yeah, way too many times. It happens all
- 14:58Speaker 6: the time.
- 14:59Speaker 5: Yeah, okay, and even to really really really good pharmacies
- 15:03Speaker 5: because anybody can you know anybody that someone can make
- 15:06Speaker 5: a mistake or you know, lose their footing or trip
- 15:08Speaker 5: up or something, and and so you know, we see
- 15:11Speaker 5: these letters a lot where the PBM's raising a concern.
- 15:14Speaker 5: So the question is, well, how do we respond to that?
- 15:18Speaker 5: And again my advice is to respond after doing some work,
- 15:23Speaker 5: be sure that you put some effort into this letter,
- 15:26Speaker 5: and you want to respond with it's always I'll be obviously,
- 15:29Speaker 5: it's always got to be truthful. You don't ever want
- 15:31Speaker 5: to make any misrepresentation about your pharmacy when you're responding,
- 15:35Speaker 5: So you want to be truthful at all times.
- 15:38Speaker 6: You know.
- 15:38Speaker 5: Typically what we'll do is advise the pharmacy, and it's
- 15:41Speaker 5: case by case, but to acknowledge the issue, but put
- 15:46Speaker 5: it in the right kind of light. Okay, put it
- 15:49Speaker 5: in the right context, because it might be there was
- 15:51Speaker 5: a one time only mistake.
- 15:53Speaker 6: It might be as very limited in scope.
- 15:55Speaker 5: It might be that the provider manual changed at the
- 15:58Speaker 5: end of twenty four, we realize that in twenty five
- 16:02Speaker 5: the rule had changed, and you know, we fled we
- 16:04Speaker 5: fouled it up a little bit, but we're going to
- 16:06Speaker 5: fix it. So you know, you you may consider acknowledging
- 16:10Speaker 5: the error, but then you got to the main in
- 16:12Speaker 5: the same paragraph, in the same sentence of fact, you've
- 16:15Speaker 5: got to put it in context to explain it, to
- 16:18Speaker 5: explain why that happened, and then what you've done to
- 16:21Speaker 5: fix it. So you know, sometimes a pharmacists to say, hey,
- 16:24Speaker 5: maybe I shouldn't respond.
- 16:27Speaker 6: And I don't ever Jeff and I don't ever advise that.
- 16:30Speaker 5: We think you do want to respond, But then it's
- 16:33Speaker 5: going to be case by case you may want to
- 16:35Speaker 5: in this response. You know, once you've explained it, I'm
- 16:38Speaker 5: not saying give excuses because you know, we're all parents
- 16:41Speaker 5: and like you know, nobody wants an excuse, you know,
- 16:44Speaker 5: so don't give excuses, but explain. And that's one of
- 16:47Speaker 5: the lawyer's eyes. A second set of eyes on your
- 16:50Speaker 5: response were helpful to be sure that it doesn't come
- 16:52Speaker 5: across as defensive or like you're trying to skirt you know,
- 16:56Speaker 5: accountability or responsibility. But you want to put it in
- 16:59Speaker 5: some context where you know it isn't such a big deal.
- 17:02Speaker 5: Maybe it's not as big a deal as the PBM
- 17:04Speaker 5: is saying. If it is a big deal, you might
- 17:06Speaker 5: consider offering, you know, a corrective action plan.
- 17:09Speaker 6: Outline that in in your response.
- 17:12Speaker 5: Or if you're going to seek some exception to a
- 17:14Speaker 5: rule because maybe your pharmacy is different than most other
- 17:17Speaker 5: network pharmacies, that explain why you would like to seek
- 17:21Speaker 5: a little variance or exception to the rule.
- 17:24Speaker 6: But the main thing here that at.
- 17:26Speaker 5: Least I would like to counsel all pharmacies is put
- 17:30Speaker 5: some time into the letter. Be sure it's very well stated,
- 17:34Speaker 5: very convincing, very helpful, but respond quickly. If the latter
- 17:38Speaker 5: comes in on a Friday, I like to have a
- 17:41Speaker 5: good response back to the pdium if it's possible, you know,
- 17:44Speaker 5: early the following week. Even they give us seven days,
- 17:48Speaker 5: I might take four or five days. I don't like
- 17:50Speaker 5: to wait till the last minute to prove that you know,
- 17:54Speaker 5: we're listening to them.
- 17:56Speaker 4: Yeah. The the key is, you know the pharmacy wants
- 18:02Speaker 4: to avoid the risk being terminated, because every contract gives
- 18:07Speaker 4: the PBM the right to terminate the pharmacy with or
- 18:11Speaker 4: without calls, and so we want to you know, even
- 18:15Speaker 4: if we as a pharmacy have made some mistakes, and
- 18:18Speaker 4: that's okay, we all make mistakes, but we explain the mistakes,
- 18:22Speaker 4: We give the context, We explain how we are being
- 18:24Speaker 4: proactive and fixing the mistakes, so that we don't give
- 18:29Speaker 4: the PBM any kind of thoughts or ammunition about terming us.
- 18:36Speaker 5: Yeah, and one thing I might not sheel if you
- 18:38Speaker 5: don't mind. It's not why you're a question, but's real
- 18:40Speaker 5: close because I've seen I see a lot of these recently,
- 18:43Speaker 5: is where maybe a drug wholesaler sends the letters of
- 18:47Speaker 5: pharmacies as you've been engaged in these practices and you're
- 18:51Speaker 5: outside the bounds of our contract or you're dispensing too
- 18:54Speaker 5: many controls or something like that. Maybe it's not a PBM,
- 18:57Speaker 5: but it's another industry partner in this is a wholesaler.
- 19:01Speaker 5: We've had a lot of examples where we write the
- 19:03Speaker 5: letter back and put it all in the context of
- 19:06Speaker 5: what the pharmacy was doing and why it really.
- 19:09Speaker 6: Isn't what it looks like to the wholesaler.
- 19:11Speaker 5: Just the other day I got a letter back said
- 19:13Speaker 5: thank you for your detailed letter explaining your business practices
- 19:18Speaker 5: and responding to our concerns. We consider this matter closed.
- 19:21Speaker 5: So the letters are very worthwhile.
- 19:25Speaker 3: So speaking about terminations, so let's say if PBM sends
- 19:28Speaker 3: a letter to a specialty pharmacy informing them that the
- 19:31Speaker 3: PBM contract is going to be terminated and within thirty days,
- 19:36Speaker 3: how should the pharmacy respond?
- 19:38Speaker 5: Yeah, so first, yeah, first thing I would do because
- 19:42Speaker 5: you know, we all know this, but if you get
- 19:45Speaker 5: termed from one PBM, there may be obligations to report
- 19:48Speaker 5: that to others. It depends what your PSAO agreements and
- 19:51Speaker 5: what your provider agreements say, but there are certainly some
- 19:54Speaker 5: cases where you've got to report that to others.
- 19:57Speaker 6: And then they may want to do the same thing.
- 19:59Speaker 5: So it's always better to avoid termination for lots of reasons,
- 20:04Speaker 5: and there are ways to do that. We've helped pharmacies reverse,
- 20:08Speaker 5: you know, a lot of termination decisions, and the game
- 20:11Speaker 5: plan is usually something like this. The first thing we
- 20:14Speaker 5: do is we look at the contract provider manual, maybe
- 20:17Speaker 5: the PSAO agreement, maybe all of them, to confirm whether
- 20:21Speaker 5: the PBM.
- 20:22Speaker 6: Is within its rights to terminate. Although, like Jeff said,
- 20:24Speaker 6: have beendego.
- 20:25Speaker 5: A lot of these pharmacies serve under these agreements where
- 20:28Speaker 5: you can be terminated without cause or with cause, and
- 20:31Speaker 5: without cause doesn't require more than maybe sixty days, notice
- 20:35Speaker 5: something like that. So it's important to look to make
- 20:38Speaker 5: sure the PBM is correct. If they're not, then very
- 20:40Speaker 5: professionally in your response, let or to point that out.
- 20:44Speaker 5: It's important to look at the provider manual, all the
- 20:46Speaker 5: applicable agreements to see how you can appeal that, because
- 20:50Speaker 5: we've been able successfully to appeal a lot of termination
- 20:53Speaker 5: decisions by providing a lot of information to the PBM
- 20:57Speaker 5: that what they think they isn't as bad as they
- 21:01Speaker 5: think it is by any means.
- 21:03Speaker 4: Yeah, and let me interject for a second, Brad. The
- 21:05Speaker 4: whole information thing is important because the PBM usually knows
- 21:12Speaker 4: a whole lot less than what we think it does.
- 21:15Speaker 4: And we've seen Brad and I have seen this not
- 21:18Speaker 4: only with PBMs, but we handle many many criminal and
- 21:22Speaker 4: civil investigations brought by the US Department of Justice and
- 21:27Speaker 4: against all different types of healthcare providers, and so often,
- 21:34Speaker 4: whether it's the PBM we're talking about here or the
- 21:37Speaker 4: Department of Justice over in another context, they have limited information,
- 21:44Speaker 4: and so they're making decisions based on body information and
- 21:49Speaker 4: what this is human nature. We do this, all of
- 21:53Speaker 4: us do this. We fill in the gaps with our imagination.
- 21:58Speaker 4: And so a PBM maybe making you know, you know,
- 22:04Speaker 4: might be saying, Okay, we're going to term you because
- 22:07Speaker 4: we think you've done some bad stuff. Well, maybe we
- 22:11Speaker 4: did some bad stuff, but probably we didn't. What we
- 22:14Speaker 4: did do is probably not nearly as bad as a
- 22:17Speaker 4: PBM thinks. And so our job then is to fill
- 22:20Speaker 4: in those gaps where, you know, we want to make
- 22:24Speaker 4: sure that the PBM is not basing his decisions on imagination,
- 22:28Speaker 4: but it has all the facts in hand. And you know,
- 22:33Speaker 4: we've had you know, we can't guarantee hundred percent success obviously,
- 22:37Speaker 4: but we've done a pretty good job over the over
- 22:40Speaker 4: the years. Where we have some good facts, we can
- 22:42Speaker 4: move the needle and the PBM will then back off
- 22:46Speaker 4: the termination.
- 22:47Speaker 6: Well, got executly, that's exactly right.
- 22:48Speaker 5: An example that Jeff and I see a lot of is,
- 22:52Speaker 5: you know, a pharmacy goes to an inventory audit, so
- 22:55Speaker 5: they've got to prove they had enough inventory to fill
- 22:57Speaker 5: you know, X number of scripts for a certain amount
- 23:00Speaker 5: of time or whatever because the PBM's got some bad
- 23:03Speaker 5: information or they did the math the wrong way, or
- 23:05Speaker 5: maybe certain wholesalers didn't respond to their requests. So you
- 23:09Speaker 5: get terminated because you were fraudulent, because you didn't have
- 23:13Speaker 5: enough product to support all the prescriptions that you filled.
- 23:17Speaker 5: And you know, in most cases that just doesn't accurate,
- 23:20Speaker 5: it's wrong. But something fell through the cracks, you know,
- 23:23Speaker 5: maybe one of the larger wholesalers failed to respond to
- 23:26Speaker 5: the inventory audit to the request by the PBM, Maybe
- 23:30Speaker 5: the pharmacy itself failed to provide all the records, or
- 23:32Speaker 5: maybe the pharmacy didn't explain, Hey, some of this inventory
- 23:36Speaker 5: came from our three sister pharmacies across the country when
- 23:40Speaker 5: we had a shortage, know, we leaned on them for product,
- 23:43Speaker 5: but the only records we have are these, and we
- 23:45Speaker 5: didn't provide these to the PBM. So to Jeff's point,
- 23:49Speaker 5: you want to put all that in the response or
- 23:51Speaker 5: the appeal, you know, whatever it ends up looking like
- 23:54Speaker 5: to the PBM, to put it all in context and
- 23:57Speaker 5: if you you know, if some of it accurate, then
- 24:01Speaker 5: explain it, explain it. If if none of it's accurate,
- 24:05Speaker 5: then certainly rebutt it, but in any event, you know,
- 24:07Speaker 5: you got to figure out what your rights are. You
- 24:09Speaker 5: got to jump on that right away and don't assume
- 24:11Speaker 5: you're going to get an extension. A lot of times
- 24:13Speaker 5: we'll get involved by pharmacies, maybe on a Friday when
- 24:17Speaker 5: our response is due the next week, and we can
- 24:19Speaker 5: usually get an extension, but not always.
- 24:22Speaker 6: So it's important to jump on.
- 24:24Speaker 5: That right away in the very unlikely event that you're
- 24:29Speaker 5: going to be terminated and there's not a lot you
- 24:31Speaker 5: can do about it. At a minimum, I feel like
- 24:34Speaker 5: it's important for the pharmacy to get the last word
- 24:38Speaker 5: in the file, which might involve responding to everything, even
- 24:42Speaker 5: if you think it isn't going to maybe reverse the decision,
- 24:46Speaker 5: so at least you have the last word explaining we
- 24:48Speaker 5: didn't do these things you're talking about, this is what
- 24:51Speaker 5: we did, and this is all you know appropriate.
- 24:54Speaker 6: It's important to get.
- 24:54Speaker 5: That because if the PBM decides they want to send
- 24:57Speaker 5: this file over to the government just to take a look,
- 25:00Speaker 5: and you've got a long letter explained that we didn't
- 25:02Speaker 5: do these things and we shouldn't be terminated, that can
- 25:05Speaker 5: be very helpful to convince the government to not look at.
- 25:08Speaker 3: It all right, So let's talk now about a potential
- 25:13Speaker 3: domino effect. So, assuming a pharmacy is licensed in multiple states,
- 25:18Speaker 3: is a lot of our specialty pharmacy are What if
- 25:21Speaker 3: a board of pharmacy in one state brings an enforcement
- 25:24Speaker 3: action against the pharmacy, might this result in other boards
- 25:29Speaker 3: of pharmacy in other states bringing a similar type action.
- 25:35Speaker 5: Absolutely absolutely, And you know we call that the domino effects.
- 25:39Speaker 6: The merry go around. When you get on it, you
- 25:41Speaker 6: can't get off.
- 25:43Speaker 5: When a pharmacy, and most of our specially pharmacy clients,
- 25:46Speaker 5: like you said, Sheila, are licensed in multiple states, many
- 25:50Speaker 5: of them all around the country, in all fifty states,
- 25:53Speaker 5: and so you know you're going to get discipline at
- 25:57Speaker 5: some point in time in some state where you do
- 25:59Speaker 5: business for something I'm just inevitable for anybody doing business
- 26:02Speaker 5: all over the country, if only because maybe a rule
- 26:06Speaker 5: change or a law change and the pharmacy wasn't aware
- 26:09Speaker 5: there was anployee air or something like that. Innocent enough,
- 26:12Speaker 5: but it does result in discipline in a state. The
- 26:16Speaker 5: first thing we like to bi advise clients to do
- 26:18Speaker 5: is in the stay where you've got the problem, obviously
- 26:21Speaker 5: address it.
- 26:21Speaker 6: Very proactively and at the end of the.
- 26:24Speaker 5: Day try to get a resolution with that state that
- 26:28Speaker 5: would not qualify as discipline. Maybe an educational effort is required,
- 26:33Speaker 5: maybe you have to pay a certain fee, but maybe
- 26:37Speaker 5: it's something that isn't even discipline, so it isn't necessarily
- 26:41Speaker 5: reportable to all your other states.
- 26:43Speaker 6: But let's say that it is. Let's say it is discipline.
- 26:46Speaker 6: The best you can get.
- 26:47Speaker 5: Is a thousand dollars buye and a slap on the wrist,
- 26:50Speaker 5: and you've got to report that to your other states.
- 26:53Speaker 5: Advice we can get pharmacies is have somebody on the team,
- 26:56Speaker 5: and you know a lot of those you want to
- 26:58Speaker 5: touch meation to your counsel, just to be your dot
- 27:01Speaker 5: in your eyes and crossing your tea's around the country.
- 27:03Speaker 5: But be sure you report that in a timely manner
- 27:06Speaker 5: to all the states where you do business, but also
- 27:10Speaker 5: with an explanation. And the idea there is that you
- 27:13Speaker 5: don't want all the states down the line where you
- 27:15Speaker 5: do business the other forty nine to necessarily implement or
- 27:21Speaker 5: put into place some kind of discipline.
- 27:23Speaker 6: We call it sister state discipline.
- 27:25Speaker 5: But you want to avoid that result as much as
- 27:27Speaker 5: you can, so the first thing is be sure you
- 27:29Speaker 5: report discipline timely to your other states. But then it's
- 27:34Speaker 5: important to put it in context of what actually happened.
- 27:37Speaker 6: And an example I worked on kind of recently was
- 27:40Speaker 6: where a.
- 27:40Speaker 5: Pharmacy around the country, especially pharmacy doing business everywhere, ran
- 27:44Speaker 5: a foul of a rule in Florida.
- 27:47Speaker 6: It's a very unique rule to Florida.
- 27:49Speaker 5: It wasn't consequential to patient health for anything else as frankly,
- 27:53Speaker 5: kind of a technical violation. But in the end the
- 27:56Speaker 5: pharmacy had to pay some penalty to Florida. But when
- 28:02Speaker 5: we advise the client how to report that to all
- 28:04Speaker 5: the other states, you know, we were beating up on Florida.
- 28:07Speaker 5: We just put it in the context of it's a
- 28:09Speaker 5: very specific rule in Florida. Here's what it was, here's
- 28:13Speaker 5: how we didn't here's how we had to pay the
- 28:15Speaker 5: thousand dollars fine, Here's why it shouldn't matter to you.
- 28:19Speaker 5: And then they reported that to all their other states,
- 28:22Speaker 5: and the dominoes didn't fall because the other states were satisfied. Oh,
- 28:25Speaker 5: that was a very specific Florida issue. Nothing that we
- 28:29Speaker 5: need to get our own pound of flesh or discipline on.
- 28:32Speaker 5: So The best advice there, I think is for multi
- 28:36Speaker 5: state specialty pharmacies. The minute you do get something that
- 28:39Speaker 5: looks like discipline, check what the reporting requirements are at
- 28:42Speaker 5: all your states. Some have less, you know, once they
- 28:45Speaker 5: might say, hey, in five days, you've got to report
- 28:48Speaker 5: to other states may say within thirty days.
- 28:51Speaker 6: So what you might want to do is to report
- 28:52Speaker 6: it to all your states.
- 28:54Speaker 5: Within five days, so you don't take any chances on
- 28:57Speaker 5: Michigan state, which if you do missis state, say Illinois,
- 29:02Speaker 5: for example, then Illinois might say, okay, we're going to
- 29:04Speaker 5: start a discipline reaction against the pharmacy because they failed
- 29:08Speaker 5: to report this Florida discipline to us, which is a
- 29:10Speaker 5: violation of Illinois law. Then you've got a whole new
- 29:14Speaker 5: you know, subdominoes falling down there. So it is important.
- 29:18Speaker 5: It's a great question. It's really important for the pharmacies
- 29:20Speaker 5: to assess what they've got to do to report it,
- 29:24Speaker 5: and then to take care of that in a timely manner.
- 29:27Speaker 3: All right, So now let's talk about FDC walks into
- 29:30Speaker 3: a pharmacy r It sounds like the beginning of a
- 29:31Speaker 3: bad joke, But the FDC walks into a pharmacy unannounced
- 29:34Speaker 3: and says that it's conducting an inspection. How does the
- 29:37Speaker 3: pharmacy react to that?
- 29:39Speaker 4: Well, let me tell you what not to do. This
- 29:42Speaker 4: is many many years ago, where the while the it's
- 29:48Speaker 4: a large compounding pharmacy, whereas the FDA and the state
- 29:52Speaker 4: board walked in the front door. And so what the
- 29:55Speaker 4: pharmacy did is had them go into a conference room
- 29:58Speaker 4: and gave them some coffee and then instructed the pharmacy
- 30:02Speaker 4: text to load up a bunch of compound drugs they
- 30:07Speaker 4: shouldn't have had, and to take them out to the
- 30:09Speaker 4: back alley and put down I'm serious, and put them
- 30:13Speaker 4: in and put them in the trunks of cars. But
- 30:15Speaker 4: they didn't know is that there was a whistleblower who
- 30:18Speaker 4: had already alerted the FBI, and the FBI had agents
- 30:21Speaker 4: out in the alley with video cameras videoing all this.
- 30:26Speaker 4: So after everything blew up, they came to me and said,
- 30:30Speaker 4: can you can you get us out of this? And
- 30:32Speaker 4: basically my response was, you know, I'm good, but I'm
- 30:36Speaker 4: not that good. That's what that's what sheila, that's what
- 30:40Speaker 4: we don't do. So Brad, now you can explain what
- 30:44Speaker 4: should do that's.
- 30:46Speaker 6: A good point. Let's not let's not do that.
- 30:48Speaker 5: And so you know, in terms of and I might
- 30:50Speaker 5: call that trying to outsmart the FDA, and you don't.
- 30:54Speaker 6: Want to try to do that. They've got plenty of resources.
- 30:56Speaker 5: They got plenty of investigators out there, plenty of inspectors.
- 31:00Speaker 5: So it's a great question because the FDA may call
- 31:03Speaker 5: and say, well, be your pharmacy on Monday, We'll be
- 31:06Speaker 5: there for a couple of days.
- 31:07Speaker 6: But in a lot of cases they show up on
- 31:09Speaker 6: Monday at nine am with.
- 31:12Speaker 5: A couple of inspectors and you know they plan to
- 31:15Speaker 5: be there for two or three days. So in that case,
- 31:17Speaker 5: you know, what we always tell pharmacies is you've got
- 31:19Speaker 5: to have a inspection leader. Other times they called it
- 31:23Speaker 5: a response team, but it's got to be a couple
- 31:27Speaker 5: of folks in the pharmacy and you have to have
- 31:28Speaker 5: a couple of backups trained so they know what to do.
- 31:32Speaker 5: And FDA shows up, so that it isn't you know,
- 31:34Speaker 5: off the rails. It all goes just just fine. So
- 31:36Speaker 5: you want your inspection leader, your inspection leader and their
- 31:40Speaker 5: right hand person to be there, come out and greet
- 31:43Speaker 5: the FDA. And this should all be part of a
- 31:45Speaker 5: standard operating procedure for the pharmacy that people are trained
- 31:49Speaker 5: on before FDA ever shows up. The inspection leader should
- 31:54Speaker 5: greet the FDA, take them to the conference room. Like
- 31:56Speaker 5: Jeff said, just don't take everything out the back door.
- 32:00Speaker 5: Take them to the conference room, offer them coffee or coach.
- 32:03Speaker 5: They will never take you up on that, but offer
- 32:06Speaker 5: those things, and then you know, ask questions. The first
- 32:10Speaker 5: thing you want to figure out is, well, you know,
- 32:12Speaker 5: why are you here today? And not in a real
- 32:14Speaker 5: defensive way, but you know why are you here today?
- 32:17Speaker 5: And don't put the answer.
- 32:18Speaker 6: In their mouth.
- 32:18Speaker 5: Let them explain, well, we received a complaint from a competitor,
- 32:22Speaker 5: or we have a patient complaint, or somebody got a
- 32:25Speaker 5: bad prescription, or you know, a pharmacy benefit manager alerted
- 32:30Speaker 5: this to something that was concerning to them. But if
- 32:33Speaker 5: you can find out the context for while they're there,
- 32:35Speaker 5: well why they're there. They're still going to say, but
- 32:38Speaker 5: it stay, but it kind of helps you the pharmacy
- 32:40Speaker 5: to cut to the chase on what information do you
- 32:43Speaker 5: want to provide them to kind of nip that in
- 32:45Speaker 5: the bud, to put it to rest, because it may
- 32:47Speaker 5: very well be that there's not really a basis for
- 32:50Speaker 5: them to even be there. They got some bad information,
- 32:53Speaker 5: so in a very professional way, gather information.
- 32:56Speaker 6: And then the second thing is, you know, set.
- 32:58Speaker 5: Some boundaries up, Sheila, where only certain people in the
- 33:01Speaker 5: pharmacy are responding to FDA. So that's why you want
- 33:05Speaker 5: your inspection leader in your right hand person.
- 33:08Speaker 6: In the right hand person says okay, you want these records, I'll.
- 33:11Speaker 5: Go get those for you, and then they begin gathering
- 33:14Speaker 5: them or they involve somebody else so that you're being responsive.
- 33:18Speaker 5: But the FDA isn't just walking around the pharmacy interviewing
- 33:22Speaker 5: everybody and talking to everybody, because they feel like the
- 33:25Speaker 5: inspection leader in the right hand person are getting them
- 33:27Speaker 5: what they need in a very timely way. So set
- 33:30Speaker 5: some boundaries as much as you can, be sure, well
- 33:34Speaker 5: as much as you can. Just set some boundaries, you know,
- 33:36Speaker 5: and then you know, remember what it is they're allowed
- 33:39Speaker 5: to look at what they can't look at. You should
- 33:41Speaker 5: call your lawyer at the beginning, and don't expect your
- 33:43Speaker 5: lawyer to bring the inspection to a halt, because that
- 33:46Speaker 5: almost never happens, and it's not good to even try
- 33:49Speaker 5: most cases, even ask but I think it's good to
- 33:51Speaker 5: get a healthcare lawyer on the phone right away because
- 33:54Speaker 5: and they can even meet the FDA inspectors by phone.
- 33:57Speaker 5: I've done that dozens of times, I know Jeff has.
- 33:59Speaker 5: Other t mats of ours have done that, just because
- 34:02Speaker 5: you say, hey, we're here, We're glad to be responsive,
- 34:05Speaker 5: and the lawyer can ask a few more questions too,
- 34:07Speaker 5: which is kind of helpful. And then the main thing
- 34:10Speaker 5: is to be responsive. Give them what they're entitled to,
- 34:15Speaker 5: but not things they're not. They shouldn't be asking about
- 34:18Speaker 5: marketing materials. They shouldn't be going through files that are
- 34:21Speaker 5: unrelated to the prescriptions you're filling, the product you're providing.
- 34:26Speaker 6: It shouldn't be a deep dive into the business of.
- 34:30Speaker 5: The pharmacy other than the prescriptions that the pharmacy is filling.
- 34:34Speaker 5: And then cooperate, keep your lawyer on the hook, on
- 34:37Speaker 5: the on the horn, and then you know in the end,
- 34:41Speaker 5: Sheila and I know you've certainly talked to pharmacies about
- 34:43Speaker 5: these just like we have for for you know, for
- 34:46Speaker 5: many years. We've all been in the industry for a while,
- 34:49Speaker 5: and you know, when the inspection is done, the FDA
- 34:51Speaker 5: is going to either issue a four eighty three, which
- 34:56Speaker 5: is kind of a report of deficiencies, or they're just
- 34:59Speaker 5: going to say thank you and leave. But in you know,
- 35:02Speaker 5: a lot of cases, the very best pharmacies can still
- 35:05Speaker 5: get a four eighty three which lists deficiencies. The most
- 35:08Speaker 5: important thing the pharmacy can do is, you know, don't
- 35:10Speaker 5: sign that while they're they're there.
- 35:13Speaker 6: That's way too fast.
- 35:14Speaker 5: You want to take time to sleep on it and
- 35:16Speaker 5: typically have a couple of weeks of business days to
- 35:19Speaker 5: respond to that. So then you want to get your
- 35:21Speaker 5: healthcare lawyer involved for sure, and you want to go
- 35:24Speaker 5: through and you want to prepare a written response to
- 35:26Speaker 5: the four eighty three because these can be publicly filed
- 35:29Speaker 5: by FDA. So I sure like my clients to have
- 35:32Speaker 5: a robust response next to the four eighty three that's
- 35:35Speaker 5: in the f d A file. And you know, respond
- 35:40Speaker 5: if you if there wasn't a problem, explain why there
- 35:42Speaker 5: wasn't a problem.
- 35:43Speaker 6: If there was, explain why and how you've fixed the problem.
- 35:47Speaker 4: Because yeah, and the FDA agent is not he or
- 35:51Speaker 4: she does not in the back in the back of
- 35:55Speaker 4: his or her mind knows that the pharmacy is probably
- 35:58Speaker 4: not going to sign the forty three. Sees that do
- 36:01Speaker 4: sign the forty three are the ones that have not
- 36:04Speaker 4: been educated as to what or what not to do.
- 36:07Speaker 4: As Brad said, it's a notice of deficiencies, and we
- 36:11Speaker 4: don't as a pharmacy at this juncture, we're not going
- 36:14Speaker 4: to acknowledge anything. We're not going to acknowledge deficiencies. What
- 36:18Speaker 4: we are going to say is please handles the forty
- 36:21Speaker 4: three and we'll look at it. That's what the FDA
- 36:25Speaker 4: agent expects and so and then, as Brad said, let's
- 36:31Speaker 4: be proactive and let's respond to it as quickly as
- 36:34Speaker 4: we can so we can at least try to get
- 36:39Speaker 4: some control of the narrative.
- 36:41Speaker 3: Okay, so when they sign this forty three, that is
- 36:43Speaker 3: like acknowledging, like, yep, we see that. You know you've
- 36:45Speaker 3: found something, and we're acknowledging yep, that's what happened. Is that?
- 36:48Speaker 4: Is that?
- 36:48Speaker 3: What that means?
- 36:49Speaker 6: Yeah?
- 36:50Speaker 5: Yeah, you're yeah, you're acknowledging that, and you're not providing
- 36:53Speaker 5: a response. It might be how we fixed it. You're
- 36:57Speaker 5: putting it in context, but also more importantly, how we
- 37:00Speaker 5: fixed it and how it's not going to be an
- 37:02Speaker 5: issue going forward. You want you want to take a
- 37:04Speaker 5: little bit of time, not in the not during the
- 37:06Speaker 5: heat of the moment, to.
- 37:07Speaker 6: Provide all that information.
- 37:08Speaker 5: That's why I think you know you want to take
- 37:10Speaker 5: your full two weeks or at least take a week
- 37:12Speaker 5: at least and put together a really good robust response
- 37:16Speaker 5: to the forty three because what you want to avoid, Sheila,
- 37:19Speaker 5: is that it escalates towards they then issue a warning letter.
- 37:22Speaker 5: Because once they issue a warning letter, then you know
- 37:26Speaker 5: the risk there for pharmacies besides the fact that it
- 37:28Speaker 5: just looks bad in the industry, although a lot of
- 37:31Speaker 5: good pharmacies get warning letters. But but you know what
- 37:35Speaker 5: looks bad about that is that a lot of industry
- 37:37Speaker 5: partners then become aware of the warning letter, and then
- 37:40Speaker 5: they may content the farmers and where you have some
- 37:42Speaker 5: concerns about doing business near pharmacy, about providing product to use.
- 37:46Speaker 5: So it's really important to try to steer the FDA.
- 37:50Speaker 6: Away from a warning letter.
- 37:51Speaker 5: And the best way to do that is with a
- 37:53Speaker 5: really good, robust response, a helpful response to the.
- 37:57Speaker 6: For eighty three.
- 37:59Speaker 3: But what if we're not able to steer them away,
- 38:00Speaker 3: and what do we do if the pharmacy does get
- 38:03Speaker 3: a warning letter. How do they respond to that?
- 38:05Speaker 5: Yeah, then then with a lot of well, with a
- 38:09Speaker 5: lot of detail, either explaining you know, usually these allegations
- 38:13Speaker 5: are all kind of broken down by incident.
- 38:16Speaker 6: Or by breach, by violation.
- 38:18Speaker 5: So you want to address all those in great detail
- 38:21Speaker 5: and put them in context and explain them away as
- 38:25Speaker 5: much as you can. But where you can't, certainly got
- 38:27Speaker 5: to explain what you've done to change your policies to
- 38:30Speaker 5: ensure that isn't going to be an issue going forward.
- 38:33Speaker 5: Some of some have worked on, for example, and Jeff
- 38:36Speaker 5: has worked on. You know, it might be that what
- 38:38Speaker 5: you had was an untrained employee who handled a certain
- 38:42Speaker 5: situation and unfortunately mishandled it.
- 38:45Speaker 6: So there have been.
- 38:45Speaker 5: Cases where we you know, we we dropped dome We
- 38:48Speaker 5: don't name them, we dropped dome on. Okay, this was
- 38:51Speaker 5: under the watchful eye of employee blah blah blah or whatever.
- 38:56Speaker 5: Here's the situation, and what happened was that we hadn't
- 38:59Speaker 5: tried him on this particular you know, protocol.
- 39:05Speaker 6: In a satisfactory manner.
- 39:07Speaker 5: As a result, this is how you respond, which is
- 39:09Speaker 5: why there was this violation.
- 39:11Speaker 6: What we've done now is we've retrained our.
- 39:13Speaker 5: Workforce with the following SOPs and you walk them through
- 39:16Speaker 5: why that's never going to be an issue again, well,
- 39:19Speaker 5: you put it in context of you don't say these words,
- 39:22Speaker 5: but it really isn't as bad as UFDR making it sound.
- 39:27Speaker 6: That's helpful.
- 39:28Speaker 5: That's super helpful to minimize it and then to resolve.
- 39:32Speaker 5: And in that way, if your industry partners have become
- 39:34Speaker 5: aware of it and they see the response, in a
- 39:37Speaker 5: lot of cases, they you know, frankly, they empathize with
- 39:39Speaker 5: the barmies. I'm sorry you had to go through all that.
- 39:41Speaker 5: You know, there's a lot of trouble for what wasn't
- 39:44Speaker 5: that big of a deal in most cases.
- 39:48Speaker 3: Now, let's talk about boards of pharmacy. What type of
- 39:50Speaker 3: relationships should the specialty pharmacy have with state boards of pharmacy.
- 39:55Speaker 4: Sure, I'll take the lead on that. At the end
- 39:58Speaker 4: of the day, Brad and I are a turn and
- 40:01Speaker 4: so it is extreme and Brad's license in multiple states.
- 40:04Speaker 4: I'm licensed in Texas, and so let's just use Texas
- 40:08Speaker 4: as an example. It is critical and our law lies
- 40:14Speaker 4: we can practice you know, we practice law because we
- 40:19Speaker 4: have a law license issued by the by the state bar. Well,
- 40:24Speaker 4: if the state bar doesn't like it, the state bar
- 40:27Speaker 4: thinks that Brad and I are incompetent or dishonest or something,
- 40:31Speaker 4: and Yanks are licensed, then all of a sudden, we
- 40:35Speaker 4: can't practice law anymore. And so it's critical that as
- 40:41Speaker 4: attorneys that we maintain an excellent relationship with the bar
- 40:46Speaker 4: of the state in which we have a licensed with
- 40:47Speaker 4: the same thing applies to a pharmacy. It's the state.
- 40:52Speaker 4: It's the born of pharmacy that issues the license to
- 40:55Speaker 4: the pharmacy, and the born of pharmacy yanks that license, well,
- 41:00Speaker 4: then the pharmacy is no longer a pharmacy, it's it's nothing.
- 41:04Speaker 4: And so it's critical that you know, at the end
- 41:08Speaker 4: of the day, the Border of Pharmacy has primary jurisdiction
- 41:11Speaker 4: over the pharmacy. Sure, the FDA can assert some jurisdiction
- 41:17Speaker 4: depending on the circumstances. The DEA can assert some jurisdiction
- 41:21Speaker 4: depending on the circumstances, But the primary jurisdictional body is
- 41:26Speaker 4: the Border of Pharmacy, and so it's critical that we
- 41:30Speaker 4: maintain a good relationship. Even if we think, for example,
- 41:35Speaker 4: that the Board of Pharmacy is being heavy handed, we
- 41:40Speaker 4: think it's coming down on us for something that we
- 41:44Speaker 4: didn't think we did. Even if we disagree with the
- 41:47Speaker 4: Board of Pharmacy. We treat the border pharmacy essentially the
- 41:51Speaker 4: same way that we're going to treat PBMs, and that
- 41:54Speaker 4: is win when Okay, well, there's obviously a problem because
- 41:59Speaker 4: the Border pharmacy thinks that we've mishandled something, that we've
- 42:02Speaker 4: done something wrong, even if we disagree, and if we
- 42:06Speaker 4: think the facts are on our side. Nevertheless, possessions is
- 42:10Speaker 4: nine tenths with the law. The Board of Pharmacy possesses
- 42:14Speaker 4: the pharmacy's license, and so we've got to solve the
- 42:17Speaker 4: problem in a win win sort of way. So I
- 42:23Speaker 4: guess the point I'm trying to make is may do
- 42:27Speaker 4: at all costs we maintain a good relationship with the
- 42:29Speaker 4: Border of Pharmacy. Brad your thoughts, Yeah, I totally agree.
- 42:32Speaker 5: I think it's helpful if you can have and this
- 42:34Speaker 5: requires certainly some effort on the pharmacy's part to cultivate
- 42:38Speaker 5: these relationships. If you've got your license, your license in
- 42:41Speaker 5: fifty states, you know you want to have contacts.
- 42:44Speaker 6: And as many.
- 42:45Speaker 5: State boards of pharmacy, well all of them frankly, but
- 42:48Speaker 5: at least as many as possible where you do the
- 42:51Speaker 5: significant amount of business, because if there's an issue I like,
- 42:54Speaker 5: I love it when the board of pharmacy gets one
- 42:56Speaker 5: of my clients heads up, Hey, we have an issue
- 42:58Speaker 5: here in virgin you have an issue in Texas. It
- 43:01Speaker 5: isn't formal discipline, it's an issue that's come up. We'd
- 43:03Speaker 5: like to get a response to this and to have
- 43:07Speaker 5: that kind of a good relationship with the board where
- 43:08Speaker 5: somebody's going to give you a heads up and it
- 43:11Speaker 5: happens a lot. That's really helpful, at least on a minimum,
- 43:14Speaker 5: to have a contact in every state, so if a
- 43:16Speaker 5: problem does arise, you've got somebody there that can either
- 43:19Speaker 5: vouch for you or at least knows that you're in
- 43:22Speaker 5: good standing in the state. You know, and this is
- 43:25Speaker 5: just a blip on the screen, just an issue to
- 43:27Speaker 5: address such a Jeff's point, relationships are everything, and a minimum,
- 43:32Speaker 5: know the you know, the executive director and the team there,
- 43:35Speaker 5: at least know who they are. Have somebody in your
- 43:38Speaker 5: team that has a good updated contact list, so if
- 43:41Speaker 5: a problem comes up, we can reach out to that
- 43:43Speaker 5: state proactively, either on our own or through legal counsel,
- 43:46Speaker 5: but like right away and nip the problem in the butt.
- 43:50Speaker 6: Sure.
- 43:51Speaker 3: So I think we started off talking about, you know,
- 43:52Speaker 3: the value of a compliance program right like why you
- 43:54Speaker 3: need one, and I think we've kind of talked about
- 43:56Speaker 3: some issues here that can be a little bit like daunting.
- 43:59Speaker 3: So assuming that a small, especially pharmacy, wants a compliance
- 44:03Speaker 3: program and specifically wants a compliance officer, but they can't
- 44:06Speaker 3: afford a full time compliance officer, what should the pharmacy
- 44:10Speaker 3: do well?
- 44:11Speaker 4: And is Yeah, I'll tackle this one. It's we do
- 44:15Speaker 4: the best we can. Okay. It's so, if we're a
- 44:19Speaker 4: small pharmacy and cannot afford a full time compliance officer,
- 44:22Speaker 4: then let's assign compliance duties to SUMP to a key
- 44:27Speaker 4: employee who we trust. It might be head of HR,
- 44:30Speaker 4: might be maybe head of it. It might be just
- 44:33Speaker 4: a one of our it might be a one of
- 44:38Speaker 4: our staff pharmacies, staff pharmacist, but somebody that we know
- 44:42Speaker 4: and trust, and we say, listen, we know that you
- 44:44Speaker 4: now are going to wear two hats. You're going to
- 44:46Speaker 4: be our compliance officer and you're going to be something
- 44:50Speaker 4: else we want you to. We're going to you know,
- 44:55Speaker 4: we're going to help train you as a compliance officer.
- 45:00Speaker 4: We're going to put together a written corporate compliance plan
- 45:04Speaker 4: that you need to read and understand. Here is the
- 45:07Speaker 4: telephone number of our healthcare attorney for you to reach
- 45:11Speaker 4: out to when necessary. And even though you are wearing
- 45:16Speaker 4: two or three hats, here at the pharmacy, we want
- 45:20Speaker 4: you to really focus on compliance issues. And that is
- 45:26Speaker 4: so much better than doing nothing. And then, of course,
- 45:29Speaker 4: if the pharmacy grows, then you know it's a different story.
- 45:32Speaker 4: Maybe we can have a full time compliance officer, but
- 45:35Speaker 4: even small pharmacies can have a compliance officer who is
- 45:39Speaker 4: the proverbial canary of the mind shift.
- 45:42Speaker 6: To totally agree.
- 45:44Speaker 5: And one thing I might add to that Sheila and Jeff,
- 45:47Speaker 5: is it's helpful for the pharmacy to maintain a training file,
- 45:51Speaker 5: training file for that corporate comblinance officer, even if it's
- 45:54Speaker 5: a part time job. As Jeff says, somebody else wears
- 45:57Speaker 5: two hats. Keep a file, can braneous file with all
- 46:01Speaker 5: the training compliance training they receive, all the webinars they
- 46:04Speaker 5: watch online or listen to online, all the publications they're
- 46:08Speaker 5: reading if they go to training in person, keep all
- 46:11Speaker 5: that in the file. You never do find yourself having
- 46:14Speaker 5: an answer for you know, why is Chila your compliance officer? Okay,
- 46:20Speaker 5: she wears two hats, but what is her training on compliance?
- 46:24Speaker 5: We can pull out the file and it's gonna be electronic,
- 46:26Speaker 5: but we can pull out the file and demonstrate whoever's asking. Hey,
- 46:29Speaker 5: Sheila has been through all this training and it's annual,
- 46:33Speaker 5: and she's done all these webinars and attended all these seminars.
- 46:36Speaker 5: That's very helpful to alleviate any concerns that a pharmacy
- 46:40Speaker 5: doesn't have a full time compliance officer. All right, Jeff
- 46:45Speaker 5: brad Any closing thoughts. As always, we've been talking to
- 46:49Speaker 5: t folks for about an hour.
- 46:52Speaker 4: All I can say is that stay closed to NASP.
- 46:56Speaker 4: N ASP is a great resource, and by being an
- 47:03Speaker 4: active member of NASP and serving on a various committees,
- 47:07Speaker 4: then as a pharmacy, we're really going to grow and
- 47:13Speaker 4: be successful. Understand that all of us are stakeholders. We're
- 47:17Speaker 4: in this together. A rising tide lifts all boats, and
- 47:21Speaker 4: so you know, stay, it's just so important that we
- 47:25Speaker 4: all be active members of NASP.
- 47:27Speaker 6: D totally agree, and Sheila, thank you so much for
- 47:30Speaker 6: having us.
- 47:30Speaker 5: It's a pleasure to speak to NASP members and we
- 47:33Speaker 5: appreciate you inviting us today.
- 47:36Speaker 3: No, thank you so much. And I can tell you
- 47:38Speaker 3: every time I talk to you know Perspective members and
- 47:40Speaker 3: I tell them about amazing organizations such as you know,
- 47:44Speaker 3: Brown and Fortunate Ato and the two of you, and
- 47:45Speaker 3: that your members of NSP and supporting the industry, they
- 47:48Speaker 3: always take a step back. They're like really, I'm like, yeah,
- 47:51Speaker 3: but it's awesome, right, And I'm like, just the tools,
- 47:54Speaker 3: the benefits, the resources, right, the webinars, these podcasts, everything
- 47:58Speaker 3: that you provide for for members to try to help them, right,
- 48:02Speaker 3: because you know, pharmacy unfortunately, it's a tough place.
- 48:04Speaker 4: It's a tough place. That's right, And it's a tough place.
- 48:08Speaker 4: It's complicated, it's so much of it is a gray area, Sheila.
- 48:12Speaker 4: We're all making decisions the best way we can. We
- 48:15Speaker 4: do our best. Sometimes we stumble, but we're in this together,
- 48:21Speaker 4: and as long as we're in this together, then good
- 48:24Speaker 4: things happen.
- 48:26Speaker 3: Absolutely well. I want to thank you both so much
- 48:27Speaker 3: for chatting with me and sharing all of this valuable information.
- 48:31Speaker 4: Glad to do it you guys here not bye.
- 48:34Speaker 3: As a reminder, NESP Corporate members are invited to be
- 48:37Speaker 3: my guest on one complimentary podcast per year. For more
- 48:40Speaker 3: information about this or other NASP membership benefits, please feel
- 48:44Speaker 3: free to reach out to membership at NA sp n
- 48:47Speaker 3: e t dot org or visit our website www dot NA,
- 48:52Speaker 3: sp N e t dot org. Until next time, have
- 48:55Speaker 3: a great day,